Global AAV Vector CDMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global AAV Vector CDMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global AAV Vector CDMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

AAV (Adeno-Associated Virus) vector CDMO service refers to a service provided by biotechnology companies in the field of gene therapy and vaccine development, providing customers with comprehensive technical support from AAV vector construction, production to purification. By using AAV vector CDMO services, customers can focus on the core scientific issues of gene therapy and vaccine development, while handing over the production and quality control of AAV vectors to professional service providers, thereby accelerating product research and development. and listing process.

Adeno-associated virus (AAV) belongs to the family Parvoviridae, and its genome is approximately 4.8 kb of single-stranded DNA, non-enveloped. Only with the help of helper viruses such as adenovirus or herpesvirus, the host can produce infectious AAV (adeno-associated virus).

The recombinant adeno-associated virus vector (rAAV) used in the research field is a gene vector modified from non-pathogenic wild-type AAV. There are multiple serotypes of AAV. The main difference between AAV vectors of different serotypes is the capsid protein. The protein structures of different capsid proteins bind to different extracellular receptor molecules, so different serotypes have different targeting affinities to tissues or organs. Generally speaking, AAV has 12 serotypes and more than 100 variants. Due to its high safety, low immunogenicity, and long expression cycle, AAV is known as the most suitable tool for studying gene function in vivo.

The Global Info Research report includes an overview of the development of the AAV Vector CDMO Services industry chain, the market status of Vaccine Development (Adherent Culture, Suspension Culture), Gene Therapy (Adherent Culture, Suspension Culture), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of AAV Vector CDMO Services.

Regionally, the report analyzes the AAV Vector CDMO Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global AAV Vector CDMO Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the AAV Vector CDMO Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the AAV Vector CDMO Services industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Adherent Culture, Suspension Culture).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the AAV Vector CDMO Services market.

Regional Analysis: The report involves examining the AAV Vector CDMO Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the AAV Vector CDMO Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to AAV Vector CDMO Services:

Company Analysis: Report covers individual AAV Vector CDMO Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards AAV Vector CDMO Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Vaccine Development, Gene Therapy).

Technology Analysis: Report covers specific technologies relevant to AAV Vector CDMO Services. It assesses the current state, advancements, and potential future developments in AAV Vector CDMO Services areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the AAV Vector CDMO Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

AAV Vector CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Adherent Culture
Suspension Culture

Market segment by Application
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others

Market segment by players, this report covers
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics（MolMed）
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
Exthera
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe AAV Vector CDMO Services product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of AAV Vector CDMO Services, with revenue, gross margin and global market share of AAV Vector CDMO Services from 2018 to 2023.

Chapter 3, the AAV Vector CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AAV Vector CDMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of AAV Vector CDMO Services.

Chapter 13, to describe AAV Vector CDMO Services research findings and conclusion.